The Domino Effect of Healthcare Staffing Struggles
Investing in modern, tech-enabled staffing solutions is not just about filling shifts; it’s about building…
The Domino Effect of Healthcare Staffing Struggles
Investing in modern, tech-enabled staffing solutions is not just about filling shifts; it’s about building more resilient organizations that anticipate labor demands, prioritize patient care, and achieve sustainable financial health. The post The Domino Effect of Healthcare Staffing Struggles appeared first on MedCity News.
Health and Health Care Experiences of Immigrant Parents and Their Children During the Second Trump Term
This brief provides data from the 2025 KFF/New York Times Survey of Immigrants on the health and health care experiences of immigrant parents and their children in the U.S. amid the current policy environment.
Constrained Budgets Lead States to Restrict HIV Drug Access Through Ryan White
States are facing constrained budgets, putting pressure on HIV programs, including the Ryan White HIV/AIDS Program. This Policy Watch explores how state Ryan White AIDS Drug Assistance Programs (ADAPs) are responding to these budget pressures, including by restricting eligibility and reducing the scope of services offered, actions that could led to negative health outcomes for…
Can AI Help Cure America’s Healthcare Pricing Problem?
AI is not a silver bullet, but its thoughtful application to administrative automation offers one of the most realistic paths to reducing healthcare costs without sacrificing quality. The post Can AI Help Cure America’s Healthcare Pricing Problem? appeared first on MedCity News.
Medicaid Is Paying for More Dental Care. GOP Cuts Threaten To Reverse the Trend.
Star Quinn moved to Kingsport, Tennessee, in 2023, the same year the state began covering dental costs for about 600,000 low-income adults enrolled in Medicaid. But when Quinn chipped a tooth and it became infected, she could not find a dentist near her home who would accept her government health coverage and was taking new…
Families Defend Disability Services Amid Medicaid Cuts
Families of Idahoans with disabilities say their lives could be upended as lawmakers in the state’s Republican-dominated legislature mull sweeping cuts. Services at risk include the 24/7 care that allows a 39-year-old with cerebral palsy to live independently; the in-home caregiving that lets a 26-year-old with brain damage from a hemorrhage at birth stay in…
Health Gorilla Calls Epic Lawsuit ‘Attack on Interoperability’ in Motion to Dismiss
Health data company Health Gorilla filed a motion to dismiss a lawsuit from Epic and several healthcare providers alleging inappropriate access to nearly 300,000 patient records. The case highlights ongoing questions about governance and standards for national health data sharing, with Health Gorilla arguing the dispute should be handled through interoperability networks’ internal processes rather…
MedCity FemFwd: Inside Build Health International’s New Maternal Center of Excellence in Sierra Leone
In this episode, we’re joined by Allison Adamson, an architect at Build Health International. We discuss Build Health International’s new Maternal Center of Excellence in Sierra Leone. The post MedCity FemFwd: Inside Build Health International’s New Maternal Center of Excellence in Sierra Leone appeared first on MedCity News.
GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs
GoodRx launched GoodRx Employer Direct, a program that allows employers to subsidize manufacturer-sponsored prices for high-cost brand medications like GLP-1s without adding them to their health insurance benefits. The post GoodRx Launches Employer Program to Help Subsidize High-Cost Brand Drugs appeared first on MedCity News.
Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions
Atrium spun out of Avidity Biosciences, which Novartis acquired in a $12 billion deal. The Atrium pipeline is led by two RNA therapies with a path to the clinic for rare inherited cardiological disorders that have no FDA-approved drugs. The post Atrium Therapeutics Launches With $270M for RNA Therapies Addressing Rare Cardio Conditions appeared first…
